Skip to main content

Abstract

Saudi Arabia has a well-developed national medicine policy as well as a well-established drug regulatory framework. Moreover, there is a well-defined pharmaceutical pricing policy, and the medicine prices are strictly controlled. The Saudi Pharmaceutical market is the largest market in the Middle East and African (MEA) region. Moreover, it is heavily dependent on imported medicines and dominated by patented and original medicines. Regarding rational use of medicines, there are several issues that need to be addressed. These include unrestricted access to medicines in the community pharmacies. Moreover, the involvement of community pharmacists in promoting rational use of medicines is currently limited. Additionally, generic medicines are still underutilized in the healthcare system. The way forward is the full implementation of these policies and the stricter enforcement of the laws governing medicines sales and dispensing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Central Department of Statistics and Information (CDSI), Kingdom of Saudi Arabia. (2015). Facts about the kingdom [Online]. Available: http://www.cdsi.gov.sa/socandpub/resd. Accessed 8 Dec 2015.

  2. Ministry of Foreign Affairs, Kingdom of Saudi Arabia. (2006). About Saudi Arabia [Online]. Available: http://www.mofa.gov.sa/sites/mofaen/ServicesAndInformation/aboutKingDom/Pages/KingdomGeography46466.aspx. Accessed 10 Dec 2015.

  3. High Commission of Development of Arriyadh. (2013). About Riyadh [Online]. Available: http://www.arriyadh.com/Eng/ab-arriyad/index.aspx/?1=1&menuId=4701. Accessed 12 Dec 2015.

  4. World Health Organization (WHO). (2007). Saudi Arabia: Country cooperation strategy at a glance [Online]. Available: http://www.who.int/countryfocus/cooperation_strategy/ccsbrief_sau_en.pdf. Accessed 9 Dec 2015.

  5. Khaliq, A. (2012). The Saudi health care system: A view from the minaret. World Health & Population, 13(3), 52–64.

    Article  Google Scholar 

  6. Almalki, M., Fitzgerald, G., & Clark, M. (2011). Health care system in Saudi Arabia: An overview. Eastern Mediterranean Health Journal, 17(10), 784–793.

    CAS  PubMed  Google Scholar 

  7. The Spanish National Research Council (CSIC). (2013). Ranking web of hospitals- Middle East [Online]. Available: http://hospitals.webometrics.info/en/Asia_Pacifico/Middle_East. Accessed 30 June 2016.

  8. Saudi Ministry of Health (2009). Saudi national strategy of healthcare services [Online]. Available: http://www.chs.gov.sa/_layouts/CareStrategy/health.pdf. accessed 02 March 2017.

  9. Walston, S., Al-Harbi, Y., & Al-Omar, B. (2008). The changing face of healthcare in Saudi Arabia. Annals of Saudi Medicine, 28(4), 243–250.

    Article  PubMed  Google Scholar 

  10. Regional Health Systems Observatory, the Eastern Mediterranean Regional Office (EMRO), World Health Organization (WHO). (2006). Health systems profile- Saudi Arabia [Online]. Available: http://apps.who.int/medicinedocs/documents/s17308e/s17308e.pdf. Accessed 9 Dec 2015.

  11. Saudi Ministry of Health. (2008). Health statistics book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx. Accessed 4 Dec 2015.

  12. Saudi Ministry of Health. (2014). Health statistics book year [Online]. Available at: http://www.moh.gov.sa/Ministry/Statistics/book/Documents/1435.pdf. Accessed 04 Dec 2015.

  13. Saudi Ministry of Health. (2009). Health statistics book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx . Accessed 4 Dec 2015.

  14. Business Monitor International (BMI). (2015). Saudi Arabia pharmaceuticals & healthcare report Q3 2015. London, UK: Business Monitor International Ltd.

    Google Scholar 

  15. World Health Organization (WHO) (2015). Saudi Arabia national expenditure on health [Online]. Available: http://apps.who.int/nha/database/Key_Indicators_by_Country/Index/en. Accessed 12 Dec 2015.

    Google Scholar 

  16. Saudi Ministry of Health. (2011). Health statistical book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx. Accessed 4 Dec 2015.

  17. Business Monitor International (BMI). (2015). United Arab Emirates pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.

    Google Scholar 

  18. Business Monitor International (BMI). (2015). Kuwait pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.

    Google Scholar 

  19. Business Monitor International (BMI). (2015). Qatar pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.

    Google Scholar 

  20. Business Monitor International (BMI). (2015). Oman pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.

    Google Scholar 

  21. Business Monitor International (BMI). (2015). Bahrain pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.

    Google Scholar 

  22. Business Monitor International (BMI). (2013). Saudi Arabia pharmaceuticals & healthcare report Q2. London, UK: Business Monitor International Ltd.

    Google Scholar 

  23. Saudi Food and Drug Authority (SFDA). (2013). About SFDA [Online]. Available at: http://www.sfda.gov.sa/en/about/Pages/overview.aspx. Accessed 12 Dec 2015.

  24. Saudi Food and Drug Authority (SFDA)/World Health Organization (WHO).( 2012). Saudi Arabia pharmaceutical country profile. Available at: http://www.who.int/medicines/areas/coordination/Saudi_ArabiaPSCP_Narrative2012-04-18_Final.pdf . Accessed 12 Dec 2015.

  25. Executive Board of the Health Ministers’ Council for GCC States. (2014). The GCC data requirements for human drugs submission content of the dossier version 1.3 [Online]. Available: https://www.sfda.gov.sa/ar/drug/resources/DocLib2/The%20GCC%20Data%20Requirements%20for%20Human%20Drugs%20Submission%20version%201.3%20GCC%202014.pdf. Accessed 13 Dec 2015.

  26. Saudi Food & Drug Authority (SFDA). (2014). Regulatory framework for drug approvals (version 5) [Online]. Available: http://www.sfda.gov.sa/en/drug/drug_reg/Regulations/Regulatory_Framework_for_Drug_Approvals_v_5%200.pdf. Accessed 12 Dec 2015.

  27. Tantash, M. (2012). Middle East generics: Challenges & opportunities. The Journal of Gene Medicine, 9(1), 13–20.

    Article  Google Scholar 

  28. Saudi Food and Drug Authority (SFDA). (2011). Registration requirements for drug companies and manufacturers [Online]. Available: http://www.sfda.gov.sa/ar/drug/resources/DocLib2/%D8%A3%D8%B3%D8%B3%D9%88%D9%85%D8%AA%D8%B7%D9%84%D8%A8%D8%A7%D8%AA%D9%88%D8%B4%D8%B1%D9%88%D8%B7%D8%A7%D9%84%D8%AA%D8 %B3%D8%AC%D9%8A%D9%84.doc. Accessed 2 Aug 2014.

  29. Saudi Food and Drug Authority (SFDA). (2016). Guidelines and regulations. Available at: http://www.sfda.gov.sa/en/drug/drug_reg/Pages/default.aspx?news=Main. Accessed 30 June 2016.

  30. Pharmacy, Pharmaceutical Institutions and Pharmaceuticals Act (2005 in Arabic). Riyadh. Saudi Arabia. Available at: http://www.moh.gov.sa/depts/Licenses/Documents/002.pdf. Accessed 30 June 2016.

  31. Saudi Food and Drug Authority (SFDA). (2013). The rules for pricing of medicines. Available at: https://www.sfda.gov.sa/AR/DRUG/DRUG_REG/Pages/drug_reg.aspx. Accessed on 13 Jan 2017.

  32. Alnutafy, F. S. (2009). Economic analysis of the prices of generic drugs in Saudi Arabia: Are the prices of generics too high? MSc thesis: The University of Queensland, Australia.

    Google Scholar 

  33. Saudi Food and Drug Authority (SFDA). (2015). Official list of registered drugs and herbal products-2015 Available at: http://www.sfda.gov.sa/ar/drug/search/Pages/default.aspx. Accessed 10 Dec 2015.

  34. Bawazir, S. A., Alkudsi, M. A., Al Humaidan, A. S., Al Jaser, M. A., & Sasich, L. D. (2013). Pharmaceutical policies used by private health insurance companies in Saudi Arabia. Saudi Pharmaceutical Journal, 21(3), 267–276.

    Article  PubMed  Google Scholar 

  35. Cooperative Health Act. (1999). Riyadh. Saudi Arabia.

    Google Scholar 

  36. Cooperative Health Insurance Policy (amended). (2009). Riyadh. Saudi Arabia.

    Google Scholar 

  37. Health Professions Practice Act. (2005). Riyadh. Saudi Arabia.

    Google Scholar 

  38. National Unified Procurement Company (NUPCO). (2016). About NUPCO [Online]. Available: http://www.nupco.com/web/en/about-nupco. Accessed 20 Mar 2016.

  39. The Saudi Center for Evidence Based Healthcare (EBHC). (2015). About Us. Available at: http://www.moh.gov.sa/endepts/Proofs/Pages/Definition.aspx. Accessed 12 Dec 2015.

  40. World Health Organization (WHO) (2001). How to develop and implement a national drug policy [Online]. Available: http://apps.who.int/medicinedocs/en/d/Js2283e/. Accessed 13 Dec 2015.

  41. Cameron, A., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Laing, R. O. (2012). Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value in Health, 15(5), 664–673.

    Article  PubMed  Google Scholar 

  42. Godman, B., Shrank, W., Wettermark, B., Andersen, M., Bishop, I., Burkhardt, T., Garuolienè, K., Kalaba, M., Laius, O., Joppi, R., Sermet, C., Schwabe, U., Teixeira, I., Tulunay, F. C., Wendykowska, K., Zara, C., & Gustafsson, L. L. (2010). Use of generics—a critical cost containment measure for all healthcare professionals in Europe? Pharmaceuticals, 3(8), 2470–2494.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cameron, A., Ewen, M., Ross-Degnan, D., Ball, D., & Laing, R. (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. The Lancet, 373(9659), 240–249.

    Article  CAS  Google Scholar 

  44. Executive Regulations of Health Professions Practice Act. (2006). Riyadh. Saudi Arabia.

    Google Scholar 

  45. Albadr, Y., & Khan, T. M. (2015). Factors influencing community pharmacist decision to dispense generic or branded medicines; Eastern Province, Alahsa. Saudi Arabia. Saudi Pharmaceutical Journal, 23(2), 143–146.

    Article  PubMed  Google Scholar 

  46. Alrasheedy, A. A., Hassali, M. A., Aljadhey, H., Ibrahim, M. I. M., AL-Tamimi, S. K. (2013). A qualitative exploration of generic substitution practice of community pharmacists in Riyadh, Saudi Arabia. 1st National Conference on Quality Use of Medicine. Selangor, Malaysia.

    Google Scholar 

  47. Salhia, H. O., Ali, A., Rezk, N. L., & El Metwally, A. (2015). Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study. Saudi Pharmaceutical Journal, 23(4), 397–404.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Albarraq, A. (2013). Consumers’ perceptions on generic medicines in Taif city, Saudi Arabia. Saudi Journal for Health Sciences, 2(1), 18–22.

    Article  Google Scholar 

  49. Al-Hassan, M. (2009). A look at community pharmacy practice in Saudi Arabia. Research Journal of Medical Sciences, 3(3), 111–114.

    Google Scholar 

  50. Najjar, T. A. (2001). A survey on community pharmacies in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal, 9(2), 113–118.

    Google Scholar 

  51. Bawazir, S. A. (2004). Consumer attitudes towards community pharmacy services in Saudi Arabia. The International Journal of Pharmacy Practice, 12(2), 83–89.

    Article  Google Scholar 

  52. Khan, T. M., & Ibrahim, Y. (2013). A qualitative exploration of the non-prescription sale of drugs and incidence of adverse events in community pharmacy settings in the eastern province of the Kingdom of Saudi Arabia. European Journal of Hospital Pharmacy, 20(1), 26–31.

    Article  Google Scholar 

  53. Abdulhak, A. B., Al Tannir, M., Almansor, M., Almohaya, M., Onazi, A., Marei, M., Aldossary, O., Obeidat, S., Obeidat, M., & Riaz, M. (2011). Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A cross sectional study. BMC Public Health, 11(1), 538.

    Article  Google Scholar 

  54. Al-Freihi, H., Ballal, S. G., Jaccarini, A., Young, M. S., Abdul-Cader, Z., & El Mouzan, M. (1987). Potential for drug misuse in the eastern province of Saudi Arabia. Annals of Saudi Medicine, 7, 301–305.

    Google Scholar 

  55. Al-Ghamdi, M. S. (2001). Empirical treatment of uncomplicated urinary tract infection by community pharmacist in the eastern province of Saudi Arabia. Saudi Medical Journal, 22(12), 1105–1108.

    CAS  PubMed  Google Scholar 

  56. Al-Mohamadi, A., Badr, A., Bin Mahfouz, L., Samargandi, D., & Al, A. A. (2013). Dispensing medications without prescription at Saudi community pharmacy: Extent and perception. Saudi Pharmaceutical Journal, 21(1), 13–18.

    Article  CAS  PubMed  Google Scholar 

  57. Bawazir, S. (1992). Prescribing pattern at community pharmacies in Saudi Arabia. International Pharmacy Journal, 6(5), 222–224.

    Google Scholar 

  58. Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014). Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet Infectious Diseases, 14(8), 742–750.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alian A. Alrasheedy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Alrasheedy, A.A., Hassali, M.A., Wong, Z.Y., Aljadhey, H., AL-Tamimi, S.K., Saleem, F. (2017). Pharmaceutical Policy in Saudi Arabia. In: Babar, ZUD. (eds) Pharmaceutical Policy in Countries with Developing Healthcare Systems. Adis, Cham. https://doi.org/10.1007/978-3-319-51673-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51673-8_16

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-51672-1

  • Online ISBN: 978-3-319-51673-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics